HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HEV infection in French HIV-infected patients.

AbstractOBJECTIVES:
The reported prevalence of anti-hepatitis E virus antibodies in HIV-positive patients from industrialized countries varies greatly. It is also difficult to compare these data with the anti-IgG prevalence in the general population because age and sex are not matched in most studies. Moreover, MSM are at increased risk of viral hepatitis.
METHODS:
HEV is endemic in southwestern France. We investigated therefore 300 HIV-infected patients consecutively attending the out-patient clinic of Toulouse University Hospital. Each HIV-infected patient was matched for sex and age with 2 healthy blood donors from the same area. They were tested for anti-HEV IgM and IgG.
RESULTS:
Anti-HEV IgG was found in 116 HIV-infected patients (38.7%) and in 284 matched controls (47.3%, p = 0.027). However, anti-HEV IgG concentration tended to be lower in HIV-patients than in controls. Anti-HEV IgM prevalence was similar HIV-infected patients (3.6%) and in matched controls (3.8%, p = 0.85).
CONCLUSION:
The prevalence and concentrations of anti-HEV IgG in HIV-infected patients from Southern-France were lower than in controls, suggesting a weaker humoral response. But their prevalences of anti-HEV IgM were similar, indicating a high incidence of HEV infection. These data do not indicate that HEV is transmitted sexually.
AuthorsFlorence Abravanel, Sébastien Lhomme, Mélanie Fougère, Karine Saune, Muriel Alvarez, Jean-Marie Péron, Pierre Delobel, Jacques Izopet
JournalThe Journal of infection (J Infect) Vol. 74 Issue 3 Pg. 310-313 (03 2017) ISSN: 1532-2742 [Electronic] England
PMID27998748 (Publication Type: Journal Article)
CopyrightCopyright © 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Hepatitis Antibodies
  • Immunoglobulin G
  • Immunoglobulin M
  • RNA, Viral
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Donors
  • Female
  • HIV Infections (complications, immunology, virology)
  • Hepatitis Antibodies (blood)
  • Hepatitis E (complications, epidemiology, immunology, transmission)
  • Hepatitis E virus (immunology)
  • Humans
  • Immunoglobulin G (blood)
  • Immunoglobulin M (blood)
  • Incidence
  • Male
  • Middle Aged
  • Outpatients
  • Prevalence
  • RNA, Viral (blood)
  • Seroepidemiologic Studies
  • Sexual Behavior
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: